Complejo Hospitalario de Toledo -ko ikertzaileekin lankidetzan egindako argitalpenak (3)

2020

  1. Drug Retention Rate and Causes of Discontinuation of Adalimumab in Uveitis: Real-World Data from the Biotherapies in Uveitis (BioÚvea) Study Group

    Ophthalmology

2013

  1. Usefulness of adalimumab in the treatment of refractory uveitis associated with juvenile idiopathic arthritis

    Mediators of Inflammation, Vol. 2013

2012

  1. Treatment of refractory uveitis with adalimumab: A prospective multicenter study of 131 patients

    Ophthalmology, Vol. 119, Núm. 8, pp. 1575-1581